PubRank

Giuseppe Nappi

Author PubWeight™ 110.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia 2012 2.48
2 Spontaneous intracranial hypotension syndrome: report of twelve cases. Headache 2004 2.26
3 Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008 1.96
4 Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009 1.95
5 Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain 2011 1.75
6 Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache 2009 1.54
7 Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005 1.20
8 Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain 2013 1.16
9 REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord 2008 1.15
10 Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain 2014 1.14
11 Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil 2003 1.11
12 Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012 1.10
13 Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain 2004 1.08
14 Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 2009 1.05
15 A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009 1.03
16 REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord 2006 1.03
17 Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics 2002 1.02
18 Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res 2009 1.02
19 Nitroglycerin induces hyperalgesia in rats--a time-course study. Eur J Pharmacol 2003 0.99
20 Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 2007 0.99
21 Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003 0.97
22 Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache 2006 0.97
23 From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain 2009 0.97
24 Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord 2006 0.97
25 Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf 2002 0.96
26 Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 2011 0.95
27 Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett 2002 0.95
28 Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord 2009 0.94
29 Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain 2010 0.93
30 Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. Neurosci Lett 2004 0.91
31 Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia 2010 0.91
32 Childhood and adolescent migraine: a neuropsychiatric disorder? Med Hypotheses 2011 0.91
33 Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta 2005 0.90
34 Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis 2005 0.90
35 Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain 2010 0.89
36 An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain 2012 0.89
37 The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett 2009 0.88
38 Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology 2005 0.87
39 Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization. Mov Disord 2011 0.87
40 Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Funct Neurol 2007 0.87
41 Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache 2012 0.87
42 Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies. Clin Biochem 2010 0.87
43 Use of complementary and alternative medicine by patients with cluster headache: results of a multi-centre headache clinic survey. Complement Ther Med 2007 0.87
44 Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model. J Headache Pain 2014 0.86
45 A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol 2007 0.86
46 Effects of anandamide in migraine: data from an animal model. J Headache Pain 2011 0.86
47 Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens 2011 0.85
48 Reproductive life milestones in women with Parkinson's disease. Funct Neurol 2004 0.85
49 Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neurobiol Dis 2007 0.85
50 Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat. Int Rev Neurobiol 2009 0.85
51 Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med 2004 0.85
52 Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs 2003 0.84
53 Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem 2004 0.84
54 Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease. Neurobiol Dis 2006 0.84
55 Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test. Eur J Pharmacol 2006 0.84
56 Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci 2008 0.84
57 Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain 2013 0.83
58 Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches. Menopause 2006 0.83
59 Evaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation. World J Gastroenterol 2006 0.83
60 Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity. J Headache Pain 2010 0.83
61 The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study. Parkinsonism Relat Disord 2009 0.83
62 Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. Headache 2012 0.82
63 An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans. J Pain 2013 0.82
64 Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. Mov Disord 2010 0.82
65 Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson's disease. Ann N Y Acad Sci 2003 0.82
66 Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the 'CARE' protocol). Cephalalgia 2013 0.82
67 Neurophysiological approach to central pain modulation in primary headaches. J Headache Pain 2005 0.82
68 Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. Brain Res 2007 0.81
69 Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine. J Headache Pain 2015 0.81
70 Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet 2002 0.81
71 Comparative analysis of the neuronal activation and cardiovascular effects of nitroglycerin, sodium nitroprusside and L-arginine. Brain Res 2005 0.81
72 The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias. Curr Neuropharmacol 2015 0.81
73 Effects of nimesulide on nitric oxide-induced hyperalgesia in humans--a neurophysiological study. Eur J Pharmacol 2002 0.81
74 Medication-overuse headache and personality: a controlled study by means of the MMPI-2. Headache 2009 0.81
75 Antioxidant effect of sulphurous thermal water on human neutrophil bursts: chemiluminescence evaluation. Respiration 2007 0.81
76 Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes. Funct Neurol 2007 0.80
77 Neuroprotective effect of nitroglycerin in a rodent model of ischemic stroke: evaluation of Bcl-2 expression. Int Rev Neurobiol 2007 0.80
78 Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: a comparative study using MMPI-2. Headache 2011 0.80
79 Migraine with and without aura: electrophysiological and functional neuroimaging evidence. Funct Neurol 2005 0.80
80 Meeting patient expectations in migraine treatment: what are the key endpoints? J Headache Pain 2008 0.80
81 Planning availability in stroke rehabilitation units. Funct Neurol 2004 0.79
82 Serious games for screening pre-dementia conditions: from virtuality to reality? A pilot project. Funct Neurol 2014 0.79
83 IkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxide. Brain Res 2010 0.79
84 Triptan nonresponders: do they exist and who are they? Cephalalgia 2013 0.79
85 A CARE: pathway in medication-overuse headache: the experience of the Headache Centre in Pavia. J Headache Pain 2005 0.79
86 Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population. Funct Neurol 2004 0.79
87 Focus on therapy of primary stabbing headache. J Headache Pain 2010 0.79
88 Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex. Eur J Neurosci 2003 0.79
89 The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review. Aging Clin Exp Res 2012 0.79
90 Ictal and interictal hypoactivation of the occipital cortex in migraine with aura. A neuroimaging and electrophysiological study. Funct Neurol 2006 0.79
91 Exploiting the full width of the therapeutic window to salvage the ischemic penumbra: imaging for a cost-effective personalized therapy. Funct Neurol 2007 0.79
92 Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia. Brain Res 2008 0.78
93 Episodic cluster headache: NREM prevalence of nocturnal attacks. Time to look beyond macrostructural analysis? Headache 2010 0.78
94 Patients with headache and functional dyspepsia present meal-induced hypersensitivity of the stomach. J Headache Pain 2005 0.78
95 Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders. Psychiatr Genet 2003 0.78
96 Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy. BMC Health Serv Res 2005 0.78
97 Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. Eur J Clin Pharmacol 2014 0.78
98 Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans. Neurol Sci 2013 0.78
99 Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 2004 0.78
100 Role of 2 common variants of 5HT2A gene in medication overuse headache. Headache 2010 0.78
101 A questionnaire on sleep and mental disorders in Parkinson's disease (QSMDPD): development and application of a new screening tool. Funct Neurol 2004 0.78
102 Focus on therapy of hypnic headache. J Headache Pain 2010 0.77
103 5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms. Eur J Pharmacol 2007 0.77
104 Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias. Clin Neuropharmacol 2009 0.77
105 The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients. Eur J Pharmacol 2010 0.77
106 Effects of sulphurous water on human neutrophil elastase release. Ther Adv Respir Dis 2010 0.77
107 Neuroendocrine aspects of migraine in women. Gynecol Endocrinol 2012 0.76
108 Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia. Neurochem Res 2012 0.76
109 Is hemicrania continua a single entity or the association of two headache forms? Considerations from a case report. Headache 2008 0.76
110 Secondary cervical dystonia in iatrogenic hypoparathyroidism associated with extensive brain calcifications. Funct Neurol 2006 0.76
111 Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat. Exp Neurol 2002 0.76
112 Report of eight new cases of hypnic headache and mini-review of the literature. Funct Neurol 2003 0.76
113 Eletriptan. Expert Opin Drug Metab Toxicol 2009 0.76
114 Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes. Eur J Biochem 2004 0.76
115 Eletriptan: a review and new perspectives. Expert Rev Neurother 2006 0.76
116 Report of ten years' activity in an Alzheimer's disease assessment unit. Aging Clin Exp Res 2009 0.76
117 Cardiovascular dysautonomia as a cause of falls in Parkinson's disease. Parkinsonism Relat Disord 2006 0.76
118 Uncommon primary headaches. Curr Opin Neurol 2006 0.76
119 Free radical-scavenging activity of sulfurous water investigated by electron paramagnetic resonance (EPR) spectroscopy. Exp Lung Res 2011 0.75
120 Andrographis Paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine. Funct Neurol 2016 0.75
121 A prospective multicentre study to evaluate the consistency of the IHS diagnostic criteria, the usefulness of brain MRI for the diagnosis, follow-up and treatment management, and the outcome after high dosage 6-methylprednisolone therapy, in subjects with Tolosa-Hunt syndrome. J Headache Pain 2010 0.75
122 Cerebrovascular diseases at the C. Mondino National Institute of Neurology: from Ottorino Rossi to the present day. Funct Neurol 2011 0.75
123 Modulation of the human nociceptive flexion reflex by pleasant and unpleasant odors. Pain 2013 0.75
124 Almotriptan in the treatment of migraine. Neuropsychiatr Dis Treat 2007 0.75
125 Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014. Funct Neurol 2014 0.75
126 Chronobiological correlates of headache: three decades on. Funct Neurol 2014 0.75
127 Functional neurology at the dawn of the third millennium: the translation of neuroscience into neurology. Funct Neurol 2002 0.75
128 Reversible chorea and focal dystonia in vitamin B12 deficiency. N Engl J Med 2002 0.75
129 Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease. Funct Neurol 2003 0.75
130 Migraine auras and the eyes of the mind. Funct Neurol 2009 0.75
131 Unilateral lesion of the subthalamic nucleus enhances cortical fos expression associated with focally evoked seizures in the rat. Brain Res 2006 0.75
132 Preface. Handb Clin Neurol 2010 0.75
133 Pharmacogenomics of episodic migraine: time has come for a step forward. Pharmacogenomics 2014 0.75
134 Potential therapeutic usefulness of hydrogen peroxide in conditions of brain ischemia. Med Hypotheses 2008 0.75
135 www.cefalea.it: the first five years. J Headache Pain 2005 0.75
136 [Accidents and headache]. G Ital Med Lav Ergon 2012 0.75
137 Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology 2003 0.75
138 Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: the synergistic role of dopamine. J Cell Biochem 2008 0.75
139 Neuronal networks in emotions. Funct Neurol 2003 0.75